Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hematopoietic stem cell transplantation
Phenotype C0023434|chronic lymphocytic leukemia
Sentences 3
PubMedID- 23435461 The purpose of this analysis was to provide 6-year follow-up of the cll3x trial, which studied reduced-intensity allogeneic hematopoietic stem cell transplantation (hsct) in patients with poor-risk chronic lymphocytic leukemia (cll), and to investigate the effect of tp53, sf3b1, and notch1 mutations on hsct outcome.
PubMedID- 23014659 Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia.
PubMedID- 21106985 Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of european intergroup randomized trial comparing autografting versus observation.

Page: 1